Tiny Drug-Carrying particles aim to blast bladder cancer cells
NCT ID NCT05519241
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-stage trial tests a new drug called PPM, which are tiny particles loaded with the chemotherapy drug paclitaxel and coated with a molecule (PLZ4) that helps them target bladder cancer cells. The drug is given directly into the bladder through a catheter once a week for six weeks. The study includes up to 29 people with non-muscle-invasive bladder cancer that has not responded to the standard BCG treatment. The main goals are to find the safest dose and to get an early look at whether the drug can shrink or eliminate the cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PLZ4-coated paclitaxel-loaded micelles (PPM)
What this could lead to
If it works, this could lead to a new treatment option for bladder cancer that hasn't responded to standard therapy, potentially avoiding more invasive surgery.
What could go wrong
This is a very early Phase 1 trial with only 29 participants, so the main goal is safety and dosing, not proof of effectiveness. The drug may not work or could have unexpected side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON MUSCLE INVASIVE BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
RECRUITINGBoston, Massachusetts, 02130-4817, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact